Dry Powder Nasal Delivery of Epinephrine for the Treatment of Anaphylaxis Brought on by an Allergic Reaction
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Belhaven Biopharma, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Scott Lyman
Fiscal Year
2021
Region
Research Triangle
Project Description:
Belhaven Biopharma, Inc. received $250,000 to fund in vivo studies of its first drug candidate, a dry-powder, intranasal epinephrine for treating anaphylaxis, a severe allergic reaction.